We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.
Over 350 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions developing immuno-oncology therapies and tools.
Over 60 presentations, case studies and panel discussions focussed on the key opportunities and challenges in immuno-oncology, from therapeutic strategies and biomarker development through to clinical research.
PLUS, interactive opportunities including:
Workshop on Accelerating the Treatment & Response Rate of Cancer Immunotherapies
6 roundtable discussions on key industry growth areas within immuno-oncology
View Agenda: https://bit.ly/2QbjKSV
Day One – 21 May 2020
Discovery of Immuno-Oncology Therapies: Inhibitory Pathway & Cell-Based Approaches
Translational Immuno-Oncology
Personalised Therapies for Immuno-Oncology
Day Two – 22 May 2020
Discovery of Immuno-Oncology Therapies: Antibody and Virus-Based Approaches
Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology
